Previous 10 | Next 10 |
TEL AVIV, Israel , Jan. 8, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem cells, today announced it has entered into a securities purchase agree...
Gainers: Genetic Technologies (NASDAQ: GENE ) +120% . More news on: Genetic Technologies Limited, Cellect Biotechnology Ltd., Apache Corporation, Stocks on the move, Read more ...
Cellect Biotechnology (NASDAQ: APOP ) +141% on new patents . More news on: Cellect Biotechnology Ltd., Apellis Pharmaceuticals, Inc., Advaxis, Inc., Stocks on the move, Read more ...
Thinly traded micro cap Cellect Biotechnology (NASDAQ: APOP ) rockets 165% premarket on robust volume in reaction to its announcement that it has been notified that its patent applications in Europe and Israel for a cell-based product and a method of manufacturing a stem and...
TEL AVIV, Israel , Jan. 7, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, received official communication from two jurisdictions, the European Patent Office (EPO) and the Israeli In...
TEL AVIV, Israel , Dec. 23, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology to enable the functional selection of stem cells, has received approval to initiate the trial in the U.S. to evaluate the safety and tolerability of the ApoGraf...
Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPADS of -$0.12. More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
TEL AVIV, Israel , Nov. 19, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today reported financial and operating results for the third quarter ended September 30, 2019 and p...
Tel Aviv, Israel , Nov. 7, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, announced today that on November 6, 2019 , it received notice from the Nasdaq Listing Center that Cel...
Gainers : Neuralstem (NASDAQ: CUR ) +69% . IVERIC (NASDAQ: ISEE ) +50% . Big 5 Sporting Goods (NASDAQ: BGFV ) +31% . Clearside Biomedical (NASDAQ: CLSD ) +23% . OneSpan (NASDAQ: OSPN ) +20% . MutualFirst Financial (NASDAQ: MFSF ) +20% . Cellect Biotechnology (NASDAQ: APOP ) +21...
News, Short Squeeze, Breakout and More Instantly...
Cellect Biotechnology Ltd. Company Name:
APOP Stock Symbol:
NASDAQ Market:
Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the...
Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning. The stock has now ...